Skip to main content
. 2019 May 13;3:100048. doi: 10.1016/j.eurox.2019.100048

Table 2.

Characteristics of the IVF cycle.

Characteristics Thalassemia Unaffected p
n = 21 n = 105
Total number of follicles ≥ 11 mm 9.5 ± 7.2 11.0 ± 7.2 0.39
N. of oocytes retrieved 6.0 ± 6.2 8.4 ± 6.5 0.12
N. suitable oocytesa 5.5 ± 6.0 6.1 ± 4.7 0.60
N. of women with no suitable oocytes 1 (5%) 3 (3%) 0.52
Techniqueb 0.79
 Classical IVF 5 (25%) 31 (30%)
 ICSI 15 (75%) 71 (70%)
N. cleavage embryosb 2 [1–5] 3 [1–5] 0.51
No viable cleavage embryosb 1 (5%) 5 (5%) 1.00
N. top quality embryosb 1 [0–4.75] 2 [1–4] 0.72
No top quality embryosb 12 (60%) 78 (77%) 0.16
Embryo transferc 0.55
 Cleavage stage 14 (74%) 76 (80%)
 Blastocyst stage 5 (26%) 19 (20%)
Total N. of transfersc 0.83
 1 13 (68%) 71 (75%)
 2 4 (21%) 15 (16%)
 ≥3 2 (11%) 9 (9%)
Clinical pregnancyd 7 (33%) 37 (35%) 1.00
Live birthd 4 (19%) 34 (32%) 0.30

Data are repoorted as mean ± SD or medain [interquartile range] or number (percentage).

“Suitable oocytes’’ include metaphase II oocytes and type 1 cumulus-oocyte complex according to the European Society for Human Reproduction and Embryology Istanbul Consensus Conference, 2011.

Top quality embryo was defined as 4-cells embryo on day 2 or 8-cells embryo on day 3, with a relative degree of fragmentation 10%.

All clinical pregnancies were singletons.

a

Suitable oocytes refer to metaphase II oocytes and type 1 cumulus-oocyte complex according to the European Society for Human Reproduction and Embryology Istanbul Consensus Conference, 2011.

b

Data refer to subjects retrieving at least one suitable oocyte (n = 20 and 102 for exposed and unexposed women, respectively).

c

Data refer to patients performing embryo transfer (95 controls and 19 cases).

d

Data include both pregnancies obtained with fresh and frozen embryo transfers.